Termination of Registration of a Class of Security Under Section 12(g) (15-12g)

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 15

 

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number: 000-54129

 

 

Evolutionary Genomics, Inc.

(Exact name of registrant as specified in its charter)

 

 

4220 Morning Star Drive

Castle Rock, CO 80108

[phone]

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Stock

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)		☐
Rule 12g-4(a)(2)		☒
Rule 12h-3(b)(1)(i)		☐
Rule 12h-3(b)(1)(ii)		☐
Rule 15d-6		☐
Rule 15-22(b)		☐

Approximate number of holders of record as of the certification or notice date: 375

Pursuant to the requirements of the Securities Exchange Act of 1934, Evolutionary Genomics, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

Dated: April 28, 2023

 

 

 

Evolutionary Genomics, Inc
By:		/s/ Steve B. Warnecke
Name:		Steve B. Warnecke
Title:		Chief Executive Officer